Polar Asset Management Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Polar Asset Management Partners’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-630,410	Closed	-$13.5M	–	880
2026 Q1	$13.5M	Buy	+630,410	New	+$8.88M	0.27%	73

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Polar Asset Management Partners's DAWN Position: Q2 2026 in Review

Polar Asset Management Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 630,410 shares — an estimated $13.5M sold.

Polar Asset Management Partners first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $13.5M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Polar Asset Management Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Polar Asset Management Partners sold 630,410 Day One Biopharmaceuticals shares in Q2 2026, an estimated $13.5M.
Polar Asset Management Partners first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Polar Asset Management Partners's Day One Biopharmaceuticals position peaked at $13.5M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Polar Asset Management Partners's 13F filing for Q2 2026, filed 14 Aug 2026.